GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Viva Biotech Holdings (HKSE:01873) » Definitions » FCF Yield %

Viva Biotech Holdings (HKSE:01873) FCF Yield % : 16.11 (As of Jun. 06, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Viva Biotech Holdings FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Viva Biotech Holdings's Trailing 12-Month Free Cash Flow is HK$214 Mil, and Market Cap is HK$1,328 Mil. Therefore, Viva Biotech Holdings's FCF Yield % for today is 16.11%.

The historical rank and industry rank for Viva Biotech Holdings's FCF Yield % or its related term are showing as below:

HKSE:01873' s FCF Yield % Range Over the Past 10 Years
Min: -24.88   Med: -0.56   Max: 25.41
Current: 16.11


During the past 8 years, the highest FCF Yield % of Viva Biotech Holdings was 25.41%. The lowest was -24.88%. And the median was -0.56%.

HKSE:01873's FCF Yield % is ranked better than
98.58% of 1553 companies
in the Biotechnology industry
Industry Median: -14.28 vs HKSE:01873: 16.11

Viva Biotech Holdings's FCF Margin % for the quarter that ended in Dec. 2023 was -1.98%.


Viva Biotech Holdings FCF Yield % Historical Data

The historical data trend for Viva Biotech Holdings's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viva Biotech Holdings FCF Yield % Chart

Viva Biotech Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial -0.25 -3.89 -6.63 4.55 9.51

Viva Biotech Holdings Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.74 -1.98 12.03 16.42 -1.96

Competitive Comparison of Viva Biotech Holdings's FCF Yield %

For the Biotechnology subindustry, Viva Biotech Holdings's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Viva Biotech Holdings's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Viva Biotech Holdings's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Viva Biotech Holdings's FCF Yield % falls into.



Viva Biotech Holdings FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Viva Biotech Holdings's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=213.909 / 2248.8585
=9.51%

Viva Biotech Holdings's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-22.001 * 2 / 2248.8585
=-1.96%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Viva Biotech Holdings FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Viva Biotech Holdings FCF Yield % Related Terms

Thank you for viewing the detailed overview of Viva Biotech Holdings's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Viva Biotech Holdings (HKSE:01873) Business Description

Traded in Other Exchanges
Address
735 Ziping Road, Pudong New District, Zhoupu Town, Shanghai, CHN, 201318
Viva Biotech Holdings is an integrated drug discovery platform. The company's operating segment includes Drug discovery services and Contract Development Manufacture Organisation (CDMO) and commercialisation services. It generates maximum revenue from the Contract Development Manufacture Organisation (CDMO) and commercialisation services segment. The Contract Development Manufacture Organisation ("CDMO") and commercialisation services segment includes contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations.
Executives
Mao Chen Cheney 2101 Beneficial owner
Wu John Jiong 2201 Interest of corporation controlled by you
Fenghe Harvest Ltd 2101 Beneficial owner
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Mao Jun 2501 Other
Temasek Holdings (private) Limited 2201 Interest of corporation controlled by you
Zhou Min 2202 Interest of your spouse
Intertrust (singapore) Ltd. 2301 Trustee
Z&m International Holdings Limited 2201 Interest of corporation controlled by you
Zhang And Sons Limited 2101 Beneficial owner

Viva Biotech Holdings (HKSE:01873) Headlines

No Headlines